Radiotherapy in limited small cell lung cancer: Fractionation and timing of modalities

Pignon, 1992, Meta-analysis of thoracic radiotherapy for small-cell lung cancer, N Engl J Med, 327, 1618, 10.1056/NEJM199212033272302 Warde, 1992, Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis, J Clin Oncol, 10, 890, 10.1200/JCO.1992.10.6.890 Natale, 1982, Combination cis-platinum and etoposide in small cell lung cancer, Cancer Treat Rev, 9, 91, 10.1016/S0305-7372(82)80085-6 Sierocki, 1979, Dichlorodiammine platinum (II) and VP-16-213: An active induction regimen for small cell carcinoma of the lung, Cancer Treat Rep, 63, 1593 Lichter, 1995, Small cell lung cancer: The influence of dose and treatment volume on outcome, Semin Radiat Oncol, 5, 44, 10.1016/S1053-4296(05)80009-8 Natale, 1995, Chemotherapy in small cell lung cancer: The current state of the art, Semin Radiat Oncol, 5, 33, 10.1016/S1053-4296(05)80007-4 Thames, 1992, On the origin of dose fractionation regimens in radiotherapy, Semin Radiat Oncol, 2, 3, 10.1016/S1053-4296(05)80043-8 Tepper, 1992, Editor's comments, Semin Radiat Oncol, 2, 1, 10.1016/S1053-4296(05)80042-6 Ball, 1995, Prophylactic cranial irradiation: More questions than answers, Semin Radiat Oncol, 5, 61, 10.1016/S1053-4296(05)80012-8 Carney, 1983, In iitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphologic variants, Cancer Res, 43, 2806 Withers, 1975, Cell cycle redistribution as a factor in multifaction irradiation, Radiology, 114, 99, 10.1148/114.1.199 Johnson, 1994, Cisplatin (P) & etoposide (E)+concurrent thoracic radiotherapy (TRT) administered once vs. twice daily for limited-stage (LS) small cell lung cancer (SCLC): Preliminary results of an intergroup trial, 13, 333 Cox, 1992, Interruptions of high-dose radiation therapy for non-small cell carcinoma of the lung decrease long-term survival in favorable patients, Int J Radiat Oncol Biol Phys, 24, 195 Ball, 1994, A phase III study of accelerated radiotherapy with and without carboplatin in no small cell lung cancer (NSCLC): Interim toxicity analysis, Lung Cancer, 11, 54 Kelly, 1994, A phase I–II study of daily carboplatin in patients with reginally inoperable ono-small cell lung cancer (NSCLC), Lung Cancer, 11, 693 Thames, 1987 Saunders, 1991, Experience with CHART, Int J Radiat Oncol Biol Phys, 21, 871, 10.1016/0360-3016(91)90722-G Ang, 1992, Impact of spinal cord repair kinetics on the practice of altered fractionation schedules, Radiother Oncol, 25, 287, 10.1016/0167-8140(92)90249-T Fleck, 1990, Is prophylactic cranial irradiation indicated in small cell lung cancer, J Clin Oncol, 8, 209, 10.1200/JCO.1990.8.2.209 Lishner, 1990, Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: The Toronto experience, J Clin Oncol, 8, 215, 10.1200/JCO.1990.8.2.215 Turrisi, 1990, Brain irradiation and systemic chemotherapy for small-cell lung cancer: Dangerous Liaisons?, J Clin Onc, 8, 196, 10.1200/JCO.1990.8.2.196 Withers HR, Peters LJ, Taylor JMG: Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys (in press) Armstrong, 1991, Twice daily thoracic irradiation for limited small cell lung cancer, Int J Radiat Oncol Biol Phys, 21, 1269, 10.1016/0360-3016(91)90285-C Lebeau, 1993, A randomized trial of delayed radiotherapy in complete responder patients with small cell lung cancer, Chest, 104, 726, 10.1378/chest.104.3.726 Kies, 1987, Multimodal therapy for limited small cell lung cancer: A randomized trial of induction combination chemotherapy with or without thoracic irradiation in complete responders; and with wide field versus reduced field in partial responders: A Southwest Oncology Group tria, J Clin Oncol, 5, 592, 10.1200/JCO.1987.5.4.592 Perry, 1987, Chemotherapy with or without radiation in limited small-cell carcinoma of the lung, N Engl J Med, 316, 912, 10.1056/NEJM198704093161504 Murray, 1993, Importance of timing for thoracic irradiation in the combined modality treatment of limited small-cell lung cancer, J Clin Oncol, 11, 336, 10.1200/JCO.1993.11.2.336 Janaki, 1994, Patterns of failure and second malignancies from SWOG 8269: Concurrent cisplatin (P), etoposide (E), vincristine (V), and once-daily radiotherapy (RT) for the treatment of limited small-cell lung cancer (SCLC), 13, 331 Turrisi, 1992, Long term results of platinum etoposide (PE)+twice daily thoracic radiotherapy (TRT) for limited small-cell lung cancer, 11, 292 Turrisi, 1990, Limited small cell lung cancer: Concurrent BID thoracic radiotherapy with platinum etoposide (PE). An ECOG study, 11, 292 Johnson, 1993, Alternating chemotherapy and twice-daily thoracic radiotherapy in limitedstage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group, J Clin Oncol, 11, 879, 10.1200/JCO.1993.11.5.879 Johnson, 1991, Limited (Ltd) stage small-cell lung cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro drug sensitivity testing (DST), Lung Cancer, 7, 152, 10.1016/0169-5002(91)91917-Z Frytak, 1991, Accelerated hyperfractionated split-course thoracic radiotherapy (AHSCTRT) and infusion cisplatin-based chemotherapy (CT) for small cell lung cancer (SCLC), Lung Cancer, 7, 157, 10.1016/0169-5002(91)91938-8 Arriagada, 1990, Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma, Int J Radiat Oncol Biol Phys, 19, 1135, 10.1016/0360-3016(90)90217-8